Source-grounded facts extracted from Corvex, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Corvex, Inc. reported first quarter 2026 results: revenue $510 thousand, net income $(5.1) million, EPS $(3.13) per share.
“to AI cloud computing and renaming Movano Inc. to Corvex, Inc., effective March 23, 2026. ● Including 12 days of Corvex OpCo operations in the period, Q1’26 total revenue was $510 thousand, compared to $206 thousand in Q1’25, including $475 thousand in AI Platform and services revenue contributed during the post-close stub period. ● Deferred revenue, including”
Corvex, Inc. engaged BDO USA, P.C. as its auditor.
“ublic accounting firm and approved the engagement of BDO USA, P.C. (“BDO”) as the Company’s independent registered”
Corvex, Inc. dismissed RBSM LLP as its auditor.
“he Board of Directors of the Company approved the dismissal of RBSM LLP (“RBSM”) as the Company’s independent registered”
Corvex, Inc.: Movano filed Certificates of Designations for Series B, C, and D Preferred Stock with the Delaware Secretary of State, amending its Certificate of Incorporation (effective 2026-03-19).
“Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Series B Convertible Preferred Stock On March 19, 2026, Movano filed a Certificate of Designations of the Series B Preferred Stock with the Secretary of State of the State of Delaware (the “Series B Certificate of Designations”) in connection with the Merger referenced in Item 1.01 above.”
Corvex, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
“October 1, 2025, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”) and served as an additional basis of delisting before the Nasdaq Hearings Panel (the “Panel”). In its Quarterly Report on Form 10-Q for the fiscal year ended June 30, 2025, filed with the U.S”
Corvex, Inc.: Filed amendment to Certificate of Incorporation to effect a 1-for-10 reverse stock split as approved by stockholders and board (effective 2025-10-10).
“On October 8, 2025, Company filed with the Secretary of State of the State of Delaware an amendment to the Certificate of Incorporation to effect the Reverse Stock Split (the “Amendment”), to be effective at 12:01 a.m. Eastern Time on October 10, 2025.”
Corvex, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
“October 1, 2025, Movano Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”) and serves as an additional basis of delisting before the Nasdaq Hearings Panel (the “Panel”). In its Quarterly Report on Form 10-Q for the fiscal year ended June 30, 2025, fil”
Corvex, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1), 5550(a)(2)).
“August 21, 2025, Movano Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that because the Company had not yet filed its Form 10-Q for the quarterly period ended June 30, 2025 (the “Form 10-Q”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Filing Requirement”) requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Form 10-Q was due on August 14, 2025. The Company appealed its previous”
Corvex, Inc. engaged RBSM LLP as its auditor.
“On August 13, 2025, Movano Inc. (the “Company”), upon approval of the Company’s Audit Committee, engaged RBSM LLP (“RBSM”) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025 and interim periods.”
Corvex, Inc. incurred loan of $1,500,000 at 12.0% maturing November 4, 2025.
“On August 6, 2025, Movano Inc. (the “Company”) entered into a Loan Agreement and Promissory Note (the “Loan Agreement”) pursuant to which the Company obtained $1,500,000 in bridge financing (the “Bridge Loan”).”
Corvex, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5250(c)(1), 5810(c)(3)(A)(iv)).
“July 7, 2025, Movano Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive trading days, the Company was no longer in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”) and the late filing requirement, as set forth in Listing Rule 5250(c)(1), given the de”
Moss Adams LLP resigned as auditor of Corvex, Inc..
“On June 24, 2025, the Company was formally notified that Moss Adams LLP (“Moss Adams”), the Company’s former independent registered public accounting firm, resigned effective June 24, 2025.”
Corvex, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“May 20, 2025, Movano Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that because the Company had not yet filed its Form 10-Q for the quarterly period ended March 31, 2025 (the “Form 10-Q”), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Form 10-Q was due on May 15, 2025. The Notice states that the Company has 60 ca”
Shaheen Wirk was appointed as Director at Corvex, Inc..
“On January 2, 2025, the Board of Directors (the “Board”) of Movano Inc. (the “Company”) appointed Shaheen Wirk as a Class III director.”
Corvex, Inc.: Amendment to Certificate of Incorporation to effect a one-for-fifteen reverse stock split (effective 2024-10-29).
“On October 25, 2024, Company filed with the Secretary of State of the State of Delaware an amendment to the Certificate of Incorporation to effect the Reverse Stock Split (the “Amendment”), to be effective at 12:01 a.m. Eastern Time on October 29, 2024.”
Corvex, Inc. reported the quarter ended March 31, 2024 results: revenue $852,000.
“board of directors. Movano Health intends to use the net proceeds from the financing for working capital and general corporate purposes. ● In Q1 2024, Movano Health generated $852,000 in revenue. The Company shipped 5,305 Evie Rings in the period. ● The Company reported an operating loss of $5.8 million in Q1 2024, compared to an operating loss of $7.2 million”
Corvex, Inc. reported financial results for the quarter and year ended December 31, 2023.
“Movano Inc. announced its financial results for the quarter and year ended December 31, 2023.”
Corvex, Inc. entered into Registration Rights Agreement with the Purchasers (effective 2024-04-01).
“Pursuant to a registration rights agreement entered into with the Purchasers on April 1, 2024 (the “Registration Rights Agreement”), the Company agreed to file a registration statement”
Corvex, Inc. entered into Purchase Agreement with the Purchasers valued at approximately $24.2 million (effective 2024-04-02).
“On April 2, 2024, Movano Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of an aggregate of 45,298,517 units”
Corvex, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“November 14, 2023, Movano Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive trading days, the Company was no longer in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s common stock”
Corvex, Inc. entered into Underwriting Agreement with The Benchmark Company, LLC valued at gross proceeds of $3.6 million for the sale of 4,235,304 shares of common stock (effective 2023-11-14).
“On November 14, 2023, Movano Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with The Benchmark Company, LLC (the “Underwriter”) relating to an underwritten offering (the “Offering”) of 4,235,304 shares (“Shares”) of common stock (“Common Stock”).”
Corvex, Inc. reported the three months ending September 30, 2023 results: net income $9.0 million, EPS $(0.18) per basic and diluted share.
“Movano Health reported a net loss of $9.0 million and a loss of $(0.18) per basic and diluted share, in the third quarter of 2023”
Corvex, Inc. reported three months ending June 30, 2023 results: net income $7.3 million, EPS $(0.17) per basic and diluted share.
“Movano Health reported a net loss of $7.3 million and a loss of $(0.17) per basic and diluted share, in the second quarter of 2023”
Corvex, Inc.: Certificate of Amendment to Third Amended and Restated Certificate of Incorporation increasing authorized shares of common stock from 75,000,000 to 150,000,000 (effective 2023-06-21).
“On June 21, 2023, Movano Inc. filed a Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation increasing the number of authorized shares of common stock from 75,000,000 to 150,000,000 shares, as further described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 28, 2023 (the “2023 Proxy Statement”) and as approved at the Company’s 2023 Annual Meeting of Stockholders (the “2023 Annual Meeting”), with the Secretary of State of the State of Delaware.”
Corvex, Inc. shareholders approved Ratification of appointment of Moss Adams LLP as the Company’s independent registered public accounting firm for 2023 at the 2023-06-20 meeting.
“The Company’s stockholders ratified the appointment of Moss Adams LLP as the Company’s independent registered public accounting firm for 2023, with votes cast as follows: For Against Abstain 21,851,777 171,848 477,382”
Corvex, Inc. shareholders approved Approval of Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 75,000,000 to 150,000,000 shares at the 2023-06-20 meeting.
“The Company’s stockholders approved the Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 75,000,000 to 150,000,000 shares, with votes cast as follows: For Against Abstain 20,768,159 1,160,355 572,493”
Corvex, Inc. shareholders approved Election of two nominees to the Board of Directors as Class II directors at the 2023-06-20 meeting.
“On June 20, 2023, the Company held its 2023 Annual Meeting. The certified results of each of the matters voted upon at the 2023 Annual Meeting, which are more fully described in the 2023 Proxy Statement, follow. The Company’s stockholders elected the two nominees to the Company’s Board of Directors to serve for three-year terms as Class II directors, with the votes cast as follows: Director Name For Withheld Broker Non-Votes John Mastrototaro 9,501,341 534,320 12,465,346 Rubén Caballero 9,320,035 715,626 12,465,346”
Corvex, Inc. entered into Underwriting Agreement with The Benchmark Company, LLC valued at $8.0 million (effective 2023-06-13).
“On June 13, 2023, Movano Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with The Benchmark Company, LLC (the “Underwriter”) relating to an underwritten offering (the “Offering”) of 8,000,000 shares (“Shares”) of common stock (“Common Stock”).”
Corvex, Inc. reported financial results for the quarter ended March 31, 2023.
“On May 15, 2023, Movano Inc. announced its financial results for the quarter ended March 31, 2023.”
Corvex, Inc. reported the three months and year ending December 31, 2022 results: net income a net loss attributable to common stockholders of $7.9 million, or a loss of $(0.24) per basic and diluted share, in the, EPS net loss attributable to common stockholders of $30.3 million or $(0.92) per share, compared with a net loss attributabl.
“On March 20, 2023, Movano Inc. announced its financial results for the quarter and year ended December 31, 2022.”
Corvex, Inc. entered into Underwriting Agreement with Newbridge Securities Corporation valued at approximately $5.8 million (effective 2023-01-27).
“On January 27, 2023, Movano Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with Newbridge Securities Corporation (the “Underwriter”), relating to an underwritten offering (the “Offering”) of 4,644,000 shares (“Company Shares”) of common stock (“Common Stock”) and warrants to purchase up to 2,322,000 shares of Common Stock (“Warrants”).”
Corvex, Inc. reported three months ending September 30, 2022 results: net income $8.6 million, EPS $(0.26) per basic and diluted share.
“Movano Health reported a net loss attributable to common stockholders of $8.6 million, or a loss of $(0.26) per basic and diluted share, in the third quarter of 2022”
Nan Kirsten Forte was appointed as Class III Director at Corvex, Inc..
“approved an increase in the size of the Board from five to six directors and appointed Nan Kirsten Forte as a Class III director”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.